StonvexLoading…
StonvexStonvexStonvexCore line items from CBRL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-30 | Q4 2025 2025-10-31 | Annual 2025 2025-08-01 | Q2 2025 2025-05-02 |
|---|---|---|---|---|
Revenue | $1.67B | $797.19M | $3.48B | $2.62B |
Operating Income | $-32.33M | $-32.80M | $55.03M | $51.05M |
Net Income | $-23.34M | $-24.62M | $46.38M | $39.63M |
EPS (Diluted) | $-1.05 | $-1.10 | $2.06 | $1.77 |
Total Assets | $2.10B | $2.15B | $2.16B | $2.14B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $8.57M | $8.94M | $39.64M | $9.81M |
Free Cash Flow OCF − CapEx | $-64.44M | $-88.92M | $59.76M | $3.00M |
Shares Outstanding | 22.35M | 22.33M | 22.27M | 22.27M |